相关实验视频
Updated: Jun 22, 2025

13:13
Biochemical Measurement of Neonatal Hypoxia
Published on: August 24, 2011
14.1K
葡萄糖和脂质相关指标与儿童群体中阿氨酸转移酶的升高相关
Azin Momeni1, Maryam Yazdi1, Mohammad Esmail Motlagh2
1Child Growth and Development Research Center, Research Institute for Primordial Prevention of Non-Communicable Disease, Isfahan University of Medical Sciences 48455 , Isfahan, Iran.
Journal of pediatric endocrinology & metabolism : JPEM
|June 27, 2024
概括
非高密度脂蛋白胆固醇 (非HDL-C) 和胆固醇比率是儿童和青少年氨酸转移酶 (ALT) 升高的关键预测指标. 这些脂质指标可以帮助识别患有脂肪肝疾病风险的儿童个体.
科学领域:
- 儿科内分泌学 儿科内分泌学
- 代谢综合征是代谢综合征的一种.
- 临床生物化学 临床生物化学
背景情况:
- 氨氨酸转移酶 (ALT) 的升高是肝损伤的标志物.
- 识别儿童ALT升高的危险因素对于早期干预至关重要.
- 葡萄糖和脂质代谢障碍在儿童中越来越普遍.
研究的目的:
- 调查葡萄糖和脂质相关指标与儿科人口中ALT升高之间的关联.
- 评估各种脂质资料对儿童和青少年ALT升高的预测能力.
主要方法:
- 对3771名伊朗儿童和青少年 (7-18岁) 的截面分析.
- 利用了来自全国学校监控计划的数据.
- 雇佣接收器运行特征 (ROC) 曲线分析,以评估11个葡萄糖和脂质指标的预测值,以确定ALT升高.
主要成果:
- 非高密度脂蛋白胆固醇 (非高密度脂蛋白胆固醇-C),非高密度脂蛋白胆固醇-C/高密度脂蛋白胆固醇-C和TC/高密度脂蛋白胆固醇-C在总样本中显示了ALT升高的显著预测值.
- 在女孩中,非HDL-C显示出最高的预测值 (AUC,0.741).
- 在男孩中,非HDL-C/HDL-C和TC/HDL-C具有最高的预测值 (AUC,0.753).
结论:
- 非-HDL-C,非-HDL-C/HDL-C和TC/HDL-C是儿童群体ALT升高的有价值预测因素.
- 这些脂质指数可以帮助识别患有脂肪肝疾病的儿童和青少年.
- 研究结果支持在风险分层的大规模人口研究中使用这些标志物.
相关概念视频
Inborn Errors of Metabolism
153
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
153
Hypoglycemia and Glucagon
254
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
254

